Isomorphic Labs Raises $5 Billion for AI Drug Design
By The Defiant

Greenoaks and Sequoia co-led the Series C as Isomorphic prepares its first therapeutic programs for clinical trials, with Alphabet investing again.
Read it in your languageMachine translation by Google of the publisher's page
More in AI
From the blog
abra
NYSE Parent Enters Bitcoin Lending Amid Wall Street Expansion
Intercontinental Exchange, the parent company of the New York Stock Exchange, has partnered with Abra to offer institutional loans backed…
AI Stocks
Nvidia Shares Drop 4% Ahead of Earnings Report
Nvidia shares suffered another sharp decline on Monday, falling 4.12% to $156.14 as investors prepared for one of the most…
Blockchain Adoption
Wall Street Enters Solana DeFi as Jupiter Launches Lending Market
Jupiter has teamed up with Bullish to launch a lending market on Solana, enabling eligible investors to borrow against tokenized…









